Friese Randall S, Shafi Shahid, Gentilello Larry M
Parkland Memorial Hospital, Division of Burn, Trauma, Critical Care, Department of Surgery, University of Texas Southwestern Medical Center at Dallas, TX, USA.
Crit Care Med. 2006 Jun;34(6):1597-601. doi: 10.1097/01.CCM.0000217918.03343.AA.
To evaluate the association between pulmonary artery catheter (PAC) use and mortality in a large cohort of injured patients. We hypothesized that PAC use is associated with improved survival in critically injured trauma patients.
Retrospective database analysis.
A total of 268 level 1 trauma centers from across the United States.
A total of 53,312 patients admitted to the intensive care units of the trauma centers participating in the National Trauma Data Bank maintained by the American College of Surgeons.
The National Trauma Data Bank was queried to identify patients aged 16-90 yrs with complete data on base deficit, and Injury Severity Score (n=53,312). Patients were initially divided into two groups: those managed with a PAC (n=1,933) and those managed without a PAC (n=51,379). Chi-square and Student's t-test analysis were utilized to explore group differences in mortality. In a second analysis, groups were stratified by base deficit, Injury Severity Score, and age to further explore the influence of injury severity on PAC use and mortality. In addition, a logistic regression model was developed to assess the relationship between PAC use and mortality after adjusting for differences in age, mechanism, injury severity, injury pattern, and co-morbidities. Overall, patients managed with a PAC were older (45.8+/-21.3 yrs), had higher Injury Severity Score (28.4+/-13.5), worse base deficit (-5.2+/-6.5), and increased mortality (PAC, 29.7%; no PAC, 9.8%; p<.001). However, after stratification for injury severity, PAC use was associated with a survival benefit in four subgroups of patients. Each of these groups had advanced age or increased injury severity. Specifically, patients aged 61-90 yrs, with arrival base deficit worse than -11 and Injury Severity Score of 25-75, had a decrease in the risk of death with PAC use (odds ratio, 0.33; 95% confidence interval, 0.17-0.62). Three additional groups had a similar decrease in the risk of death with PAC use: odds ratio, 0.60 (95% confidence interval, 0.43-0.83), 0.82 (95% confidence interval, 0.44-1.52), and 0.63 (95% confidence interval, 0.40-0.98). Logistic regression analysis demonstrated a decreased mortality when a PAC was used in the management of patients with the following severe injury characteristics: Injury Severity Score of 25-75, base deficit of less than -11, or age of 61-90 yrs (odds ratio, 0.593; 95% confidence interval, 0.437-0.805).
Trauma patients managed with a PAC are more severely injured and have a higher mortality. However, severely injured patients (Injury Severity Score, 25-75) who arrive in severe shock, and older patients, have an associated survival benefit when managed with a PAC. This is the first study to demonstrate a benefit of PAC use in trauma patients.
评估在一大群受伤患者中使用肺动脉导管(PAC)与死亡率之间的关联。我们假设在严重受伤的创伤患者中使用PAC与生存率提高相关。
回顾性数据库分析。
来自美国各地的268个一级创伤中心。
共有53312名患者入住参与美国外科医师学会维护的国家创伤数据库的创伤中心重症监护病房。
查询国家创伤数据库以识别年龄在16 - 90岁且碱缺失和损伤严重度评分数据完整的患者(n = 53312)。患者最初分为两组:使用PAC治疗的患者(n = 1933)和未使用PAC治疗的患者(n = 51379)。采用卡方检验和学生t检验分析来探讨两组死亡率的差异。在第二项分析中,根据碱缺失、损伤严重度评分和年龄对分组进行分层,以进一步探讨损伤严重程度对PAC使用和死亡率的影响。此外,建立了一个逻辑回归模型,在调整年龄、损伤机制、损伤严重程度、损伤类型和合并症差异后,评估PAC使用与死亡率之间的关系。总体而言,使用PAC治疗的患者年龄较大(45.8±21.3岁),损伤严重度评分较高(28.4±13.5),碱缺失情况较差(-5.2±6.5),死亡率较高(使用PAC组为29.7%;未使用PAC组为9.8%;p <.001)。然而,在按损伤严重程度分层后,PAC的使用在四个患者亚组中与生存获益相关。这些组中的每一组都有高龄或损伤严重程度增加的情况。具体而言,年龄在61 - 90岁、入院时碱缺失低于-11且损伤严重度评分为25 - 75的患者,使用PAC可降低死亡风险(比值比,0.33;95%置信区间,0.17 - 0.62)。另外三个组使用PAC时死亡风险也有类似程度的降低:比值比分别为0.60(95%置信区间,0.43 - 0.83)、0.82(95%置信区间,0.44 - 1.52)和0.63(95%置信区间,0.40 - 0.98)。逻辑回归分析表明,对于具有以下严重损伤特征的患者,使用PAC进行治疗时死亡率降低:损伤严重度评分为25 - 75、碱缺失低于-11或年龄在61 - 90岁(比值比,0.593;95%置信区间,0.437 - 0.805)。
使用PAC治疗的创伤患者损伤更严重,死亡率更高。然而,严重休克入院的严重受伤患者(损伤严重度评分25 - 75)以及老年患者,使用PAC治疗时具有生存获益。这是第一项证明在创伤患者中使用PAC有益的研究。